New drug combo may fortify artery plaques after heart attacks
NCT ID NCT06791031
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 18 times
Summary
This study tests whether adding a powerful cholesterol-lowering drug (PCSK9 inhibitor) to standard statin therapy soon after a heart attack can make artery plaques thicker and more stable. About 212 adults who recently had a heart attack and underwent stenting will be randomly assigned to receive either the extra drug or standard care for 6 months. The main goal is to see if the plaques in non-treated arteries become less likely to rupture, which could reduce future heart problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.